Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Interaction of Trospium with Ranitidine and Clarithromycin
NCT03011463Phase 1Completed
- Sponsor
- Dr. Pfleger
- Start
- Nov 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of trospium in overactive bladder (OAB) (6 arms), sponsored by Dr. Pfleger. Primary endpoint: absolute bioavailability. Started Nov 2016; status: completed.
02
Drugs
trospium
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT03011463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03011463.